Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
SN: Transmitter Serial Number
LBL: Artwork part number
FCC ID:FCC is a US agency that regulates
certain device communications
Replace the adhesive patch after 24 hours of use or any time that the transmitter is removed and replaced.
The sensor requires a 24-hour Warm-Up Phase to stabilize in your body before glucose values will be collected by the smart transmitter. During the Warm-Up Phase, you do not need to wear the smart transmitter. If you decide to wear the smart transmitter over the sensor during this time, you will receive a message on the app indicating the Warm-Up Phase is in progress. Once the Warm-Up Phase is complete, turn ON the smart transmitter and place it over the sensor with the Eversense® adhesive patch. The system will prompt you to calibrate using the app.
No, your sensor will continue to work for the remainder of the time (up to 3 months(2))
(2)Indicated for up to 90 days
The following steps outline how to pair your mobile device and smart transmitter.
- Launch the Eversense® App and go to the Connect screen (if pairing during installation, when you tap “I have a smart transmitter”, the Connect screen is displayed).
- Press the smart transmitter power button three times to activate “Discoverable” mode.
- When the smart transmitter blinks green and orange, tap the smart transmitter ID on the CONNECT screen. The app will then begin the searching process.
- Your smart transmitter ID is the same as the serial number listed on the back of the smart transmitter.
- When the app finds your smart transmitter, a BLUETOOTH PAIRING REQUEST pop-up screen appears.
- Tap Pair to confirm the pairing.
- The app will display Connected next to the smart transmitter ID once the pairing is completed.
NOTE: The smart transmitter should not be charging during the pairing process.
Your smart transmitter communicates with both the sensor and the app to provide CGM information.
Your Eversense® E3 Smart Transmitter does the following:
- Powers the sensor.
- Calculates and stores glucose data.
- Provides on-body vibe alerts when you have reached the glucose alert levels you set.
- Sends glucose data to the app via Bluetooth.
- Can be recharged using the charging cradle and cable.
- USB port on charging cradle can be used to download data to compatible external applications.
- Multi-color LED to indicate various modes of the smart transmitter.
- Communicates with compatible mobile device.
- Can be powered ON or OFF.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060